KARYOPHARM THERAPEUTICS INC filings

SEC filings by KARYOPHARM THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14Avidity Partners Management LPKaryopharm Therapeutics Inc.11,188,7439.5%EDGAR
SC 13G/A2024-02-14Palo Alto Investors LPKaryopharm Therapeutics Inc.5,102,1934.4%EDGAR
SC 13G2024-02-13VANGUARD GROUP INCKaryopharm Therapeutics Inc.8,710,1587.6%EDGAR
SC 13G/A2024-02-12Rubric Capital Management LPKaryopharm Therapeutics Inc.00.0%EDGAR
SC 13G/A2024-01-25BlackRock Inc.Karyopharm Therapeutics Inc.10,071,6778.8%EDGAR
SC 13G/A2024-01-22STATE STREET CORPKaryopharm Therapeutics Inc.-1.8%EDGAR
SC 13G/A2023-07-10STATE STREET CORPKaryopharm Therapeutics Inc.-1.9%EDGAR
SC 13G/A2023-02-14Avidity Partners Management LPKaryopharm Therapeutics Inc.11,381,0739.9%EDGAR
SC 13G/A2023-02-14Chione LtdKaryopharm Therapeutics Inc.4,400,0003.9%EDGAR
SC 13G/A2023-02-14Palo Alto Investors LPKaryopharm Therapeutics Inc.5,655,6765.0%EDGAR
SC 13G/A2023-02-14COMMODORE CAPITAL LPKaryopharm Therapeutics Inc.1,935,6091.7%EDGAR
SC 13G2023-02-10Rubric Capital Management LPKaryopharm Therapeutics Inc.8,294,6217.3%EDGAR
SC 13G/A2023-02-02STATE STREET CORPKaryopharm Therapeutics Inc.-7.3%EDGAR
SC 13G/A2023-01-26BlackRock Inc.Karyopharm Therapeutics Inc.8,508,23710.5%EDGAR
SC 13G2023-01-20BlackRock Inc.Karyopharm Therapeutics Inc.8,508,23710.5%EDGAR
SC 13G2022-12-08Avidity Partners Management LPKaryopharm Therapeutics Inc.11,351,8199.9%EDGAR
SC 13G2022-05-09COMMODORE CAPITAL LPKaryopharm Therapeutics Inc.4,011,0525.1%EDGAR
SC 13G/A2022-02-14Palo Alto Investors LPKaryopharm Therapeutics Inc.5,470,4527.2%EDGAR
SC 13G/A2022-02-11STATE STREET CORPKaryopharm Therapeutics Inc.-7.3%EDGAR
SC 13G/A2022-02-11Kauffman MichaelKaryopharm Therapeutics Inc.4,078,3175.2%EDGAR